PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW132519View Pathway |
Tivozanib Drug MetabolismHomo sapiens
Tivozanib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Tivozanib passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 22:14 Last Updated: September 21, 2023 at 22:14 |
PW146453View Pathway |
drug action
Tivozanib Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:14 Last Updated: October 07, 2023 at 18:14 |
PW127597View Pathway |
drug action
Tixagevimab Action PathwayHomo sapiens
Tixagevimab is an extended half-life recombinant monoclonal IgG1κ antibody directed against the SARS-CoV-2 S protein for COVID-19 prophylaxis in individuals unable to undergo COVID-19 immunization.Tixagevimab, in combination with cilgavimab, was issued an FDA emergency use authorization on December 9, 2021. The combination of drugs was packaged as EVUSHELD and was granted marketing authorization by the EMA on March 28, 2022, then it was approved in Canada later on April 14, 2022. Certain SAR-CoV-2 Omicron subvariants may be associated with resistence to EVUSHELD.
SARS-CoV-2 enters host cells via the interaction between the trimeric spike (S) glycoprotein and host cell angiotensin-converting enzyme 2 (ACE2). Cilgavimab inhibits S glycoprotein by blocking the interaction between it and the host ACE2 protein. This inhibits the binding and entry of the virion into the host cell. This prevents viral replication and propagation.
|
Creator: Ray Kruger Created On: May 12, 2023 at 09:54 Last Updated: May 12, 2023 at 09:54 |
PW132482View Pathway |
Tixocortol Drug MetabolismHomo sapiens
Tixocortol is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Tixocortol passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 22:00 Last Updated: September 21, 2023 at 22:00 |
PW145971View Pathway |
drug action
Tixocortol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:06 Last Updated: October 07, 2023 at 17:06 |
PW126665View Pathway |
drug action
TizanidineHomo sapiens
Tizanidine is an alpha-2 adrenergic agonist used for the
management of muscle spasm, which may result from the effects of multiple sclerosis, stroke, an acquired brain injury, or a spinal cord injury.
Spasticity is an increase in muscle accompanied by uncontrolled, repetitive contractions of skeletal muscles which are involuntary.
Activation of alpha-2 adrenergic receptors on the presynaptic spinal motor neurons lead to the activation of Gi signaling cascade. This inhibits adenylyl cyclase and inactivates protein kinase A, thus decreasing calcium ion entry into the cell. Calcium in the cell is responsible for triggering the release of excitatory neurotransmitters such as glutamate (and aspartate) into the synapse. Glutamate acts on AMPA and NMDA receptors on the post synaptic motor neurons. Activation of AMPA receptors causes the influx of sodium in the post synaptic neuron. Activation of NMDA receptors causes an influx of calcium into the post synaptic neuron. The influx of positive ions in the cytosol causing depolarization of the motor neurons which then transmits a signal to muscle, causing muscle contraction/excitation.
With reduced calcium entry in the presynaptic neuron, glutamate release is inhibited and less NMDA and AMPA receptors are activated, preventing depolarization of motor neurons and decreasing muscle contractions and spasms.
Common adverse effects of taking tizanidine include drowsiness, blurred vision, dry mouth, weakness, constipation, nervousness, dizziness, hallucinations, dyskinesia, rhinitis.
|
Creator: Karxena Harford Created On: February 11, 2022 at 03:46 Last Updated: February 11, 2022 at 03:46 |
PW144809View Pathway |
drug action
Tizanidine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:28 Last Updated: October 07, 2023 at 14:28 |
PW176148View Pathway |
Tizanidine Predicted Metabolism Pathway newHomo sapiens
Metabolites of Tizanidine are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:19 Last Updated: November 29, 2023 at 14:19 |
PW123840View Pathway |
signaling
TLRHomo sapiens
|
Creator: Guest: Anonymous Created On: March 22, 2020 at 14:58 Last Updated: March 22, 2020 at 14:58 |
PW123671View Pathway |
signaling
TLR2Homo sapiens
|
Creator: Guest: Anonymous Created On: December 18, 2019 at 10:47 Last Updated: December 18, 2019 at 10:47 |